Search Results

Demetrix obtains exclusive use of key intellectual property enabling the cost-effective production of cannabinoids using fermentation.

Biotechnology company signs CMO to produce metric tons of rare cannabinoids for nutraceutical, skincare, and other consumer health and wellness products

Funding Round led by Tuatara Capital with Continued Participation by Horizons Ventures

Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Combined with a Pre-Seed round raised in December 2018 led by Fifty Years, the company has raised $9.2 million to date.

Pioneering Scientist and Former CEO of Human Genome Sciences Brings Key Expertise to Grace’s Board